Mishra, JayapriyaBhatti, Gurjit KaurSehrawat, AbhishekSingh, CharanSingh, ArtiReddy, Arubala P.Reddy, P. HemachandraBhatti, Jasvinder Singh2024-01-212024-08-142024-01-212024-08-142022-11-0424320510.1016/j.lfs.2022.121153http://10.2.3.109/handle/32116/4231The high prevalence of neurodegenerative diseases has become a major public health challenge and is associated with a tremendous burden on individuals, society and federal governments worldwide. Protein misfolding and aggregation are the major pathological hallmarks of several neurodegenerative disorders. The cells have evolved several regulatory mechanisms to deal with aberrant protein folding, namely the classical ubiquitin pathway, where ubiquitination of protein aggregates marks their degradation via lysosome and the novel autophagy or mitophagy pathways. Autophagy is a catabolic process in eukaryotic cells that allows the lysosome to recycle the cell's own contents, such as organelles and proteins, known as autophagic cargo. Their most significant role is to keep cells alive in distressed situations. Mitophagy is also crucial for reducing abnormal protein aggregation and increasing organelle clearance and partly accounts for maintaining cellular homeostasis. Furthermore, substantial data indicate that any disruption in these homeostatic mechanisms leads to the emergence of several age-associated metabolic and neurodegenerative diseases. So, targeting autophagy and mitophagy might be a potential therapeutic strategy for a variety of health conditions. � 2022en-USAggregationAutophagic cargoAutophagyFunctional foodsHomeostasisMisfoldingMitophagyNeurodegenerative disordersModulating autophagy and mitophagy as a promising therapeutic approach in neurodegenerative disordersReviewhttps://linkinghub.elsevier.com/retrieve/pii/S0024320522008530Life Sciences